This is a gene of particular interest given that loss‐of‐function mutations of SLC20A2 have been identified previously in patients with early‐onset AD and other neurodegenerative disorders associated with brain calcifications.68, 69. The gene discussed is SLC20A2; the disease is Alzheimer disease.